Increased Expression of Long Noncoding RNA LOC100506314 in T cells from Patients with Nonsegmental Vitiligo and Its Contribution to Vitiligo Pathogenesis
Table 2
Regression analyses assessing the correlations between the expression levels of the mRNA transcripts with demographic data of patients with vitiligo.
Variables
Duration of disease (per year)
Sex (male/female)
Age (per 10 year)
Lnc-ARRDC3-1
1.03 (0.99–1.07)
0.72 (0.45–1.16)
1.14 (0.87–1.51)
PLCG1
1.01 (0.99–1.04)
0.91 (0.69–1.21)
1.04 (0.89–1.12)
A_33_P3229958
1.05 (0.99–1.10)
0.72 (0.41–1.42)
1.23 (0.87–1.75)
TM4SF19
1.03 (0.98–1.09)
1.63 (0.87–3.03)
1.12 (0.98–1.05)
IFI27
0.97 (0.93–1.03)
0.86 (0.47–1.60)
0.93 (0.66–1.32)
IL17RB
1.03 (0.99–1.07)
1.02 (0.65–1.58)
0.93 (0.72–1.19)
TERM1
1.02 (0.96–1.08)
0.66 (0.34–1.26)
1.04 (0.71–1.52)
RAB13
1.00 (0.97–1.04)
1.05 (0.71–1.56)
1.07 (0.86–1.34)
LOC100506314
1.05 (0.99–1.11)
0.68 (0.33–1.37)
1.37 (0.92–2.03)
Note: Data are presented as fold change with 95% confidence interval. All p values were >0.05.
